-
1
-
-
63249118690
-
Screening and prostate-cancer mortality in a randomized European study
-
Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8.
-
(2009)
N Engl J Med
, vol.360
, pp. 1320-1328
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
-
2
-
-
0025179690
-
The excess mortality rate. A useful concept in cancer epidemiology
-
Lenner P. The excess mortality rate. A useful concept in cancer epidemiology. Acta Oncol 1990;29:573-6.
-
(1990)
Acta Oncol
, vol.29
, pp. 573-576
-
-
Lenner, P.1
-
3
-
-
18844473657
-
The story of the European Randomized Study of Screening for Prostate Cancer
-
Schroder FH, Denis LJ, Roobol M, et al. The story of the European randomized study of screening for prostate cancer. BJU Int 2003;92(Suppl 2):1-13. (Pubitemid 38091131)
-
(2003)
BJU International, Supplement
, vol.92
, Issue.2
, pp. 1-13
-
-
Schroder, F.H.1
Denis, L.J.2
Roobol, M.3
-
4
-
-
0347756693
-
European randomized study of screening for prostate cancer: Achievements and presentation
-
Roobol MJ, Schroder FH. European randomized study of screening for prostate cancer: achievements and presentation. BJU Int 2003;92(Suppl 2):117-22.
-
(2003)
BJU Int
, vol.92
, Issue.SUPPL. 2
, pp. 117-122
-
-
Roobol, M.J.1
Schroder, F.H.2
-
6
-
-
0028832340
-
Cancer incidence in the Netherlands in 1989 and 1990: First results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries
-
van der Sanden GA, Coebergh JW, Schouten LJ, Visser O, van Leeuwen FE. Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer 1995;31A:1822-9.
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 1822-1829
-
-
Van Der Sanden, G.A.1
Coebergh, J.W.2
Schouten, L.J.3
Visser, O.4
Van Leeuwen, F.E.5
-
7
-
-
79251520975
-
-
CBS. CBS. 2009;1. See http://statline.cbs.nl/StatWeb/publication.
-
(2009)
CBS
, vol.1
-
-
-
8
-
-
9144236203
-
Determining the cause of death in randomized screening trial(s) for prostate cancer
-
De Koning HJ, Blom J, Merkelbach JW, et al. Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int 2003;92(Suppl 2):71-8.
-
(2003)
BJU Int
, vol.92
, Issue.SUPPL. 2
, pp. 71-78
-
-
De Koning, H.J.1
Blom, J.2
Merkelbach, J.W.3
-
11
-
-
0037051107
-
Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial
-
de Koning HJ, Liem MK, Baan CA, Boer R, Schroder FH, Alexander FE. Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial. Int J Cancer 2002;98: 268-73.
-
(2002)
Int J Cancer
, vol.98
, pp. 268-273
-
-
De Koning, H.J.1
Liem, M.K.2
Baan, C.A.3
Boer, R.4
Schroder, F.H.5
Alexander, F.E.6
-
12
-
-
0021645157
-
Additive and multiplicative models for relative survival rates
-
Buckley JD. Additive and multiplicative models for relative survival rates. Biometrics 1984;40:51-62.
-
(1984)
Biometrics
, vol.40
, pp. 51-62
-
-
Buckley, J.D.1
-
13
-
-
0033778066
-
Why do men refuse or attend population-based screening for prostate cancer?
-
Nijs HG, Essink-Bot ML, DeKoning HJ, Kirkels WJ, Schroder FH. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med 2000;22:312-6.
-
(2000)
J Public Health Med
, vol.22
, pp. 312-316
-
-
Nijs, H.G.1
Essink-Bot, M.L.2
Dekoning, H.J.3
Kirkels, W.J.4
Schroder, F.H.5
-
14
-
-
0031395394
-
Randomised trial of prostate cancer screening in the Netherlands: Assessment of acceptance and motives for attendance
-
Nijs HG, Tordoir DM, Schuurman JH, Kirkels WJ, Schroder FH. Randomised trial of prostate cancer screening in The Netherlands: assessment of acceptance and motives for attendance. J Med Screen 1997;4:102-6.
-
(1997)
J Med Screen
, vol.4
, pp. 102-106
-
-
Nijs, H.G.1
Tordoir, D.M.2
Schuurman, J.H.3
Kirkels, W.J.4
Schroder, F.H.5
-
15
-
-
3042604543
-
Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: Self-selection bias?
-
Otto SJ, Schroder FH, de Koning HJ. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias? J Med Screen 2004;11:89-92.
-
(2004)
J Med Screen
, vol.11
, pp. 89-92
-
-
Otto, S.J.1
Schroder, F.H.2
De Koning, H.J.3
-
16
-
-
0348186338
-
-
Cambridge University Press
-
Davison AC. Statistical Models. Cambridge University Press 2003:33-5.
-
(2003)
Statistical Models
, pp. 33-35
-
-
Davison, A.C.1
-
17
-
-
84952496879
-
A note on the delta method
-
Oehlert GW. A note on the delta method. Am Stat 1992;46:27-9.
-
(1992)
Am Stat
, vol.46
, pp. 27-29
-
-
Oehlert, G.W.1
-
19
-
-
0028968104
-
Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee
-
Nystrom L, Larsson LG, Rutqvist LE, et al. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995; 34:145-52.
-
(1995)
Acta Oncol
, vol.34
, pp. 145-152
-
-
Nystrom, L.1
Larsson, L.G.2
Rutqvist, L.E.3
-
20
-
-
0035814438
-
Determining cause of death in prostate cancer: Are death certificates valid?
-
Penson DF, Albertsen PC, Nelson PS, Barry M, Stanford JL. Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst 2001;93:1822-3.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1822-1823
-
-
Penson, D.F.1
Albertsen, P.C.2
Nelson, P.S.3
Barry, M.4
Stanford, J.L.5
-
21
-
-
0033958329
-
A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995
-
Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 2000;163: 519-23.
-
(2000)
J Urol
, vol.163
, pp. 519-523
-
-
Albertsen, P.C.1
Walters, S.2
Hanley, J.A.3
-
22
-
-
33744909342
-
Tumour features in the control and screening arm of a randomized trial of prostate cancer
-
Postma R, van Leenders AG, Roobol MJ, Schroder FH, van der Kwast TH. Tumour features in the control and screening arm of a randomized trial of prostate cancer. Eur Urol 2006;50:70-5.
-
(2006)
Eur Urol
, vol.50
, pp. 70-75
-
-
Postma, R.1
Van Leenders, A.G.2
Roobol, M.J.3
Schroder, F.H.4
Van Der Kwast, T.H.5
-
23
-
-
0032974261
-
Advanced prostate cancer: Course, care, and cost implications
-
Beemsterboer PM, de Koning HJ, Birnie E, van der Maas PJ, Schroder FH. Advanced prostate cancer: course, care, and cost implications. Prostate 1999;40:97-104.
-
(1999)
Prostate
, vol.40
, pp. 97-104
-
-
Beemsterboer, P.M.1
De Koning, H.J.2
Birnie, E.3
Van Der Maas, P.J.4
Schroder, F.H.5
-
24
-
-
0030340771
-
The Swedish randomised mammography screening trials: Analysis of their effect on the breast cancer related excess mortality
-
Larsson LG, Nystrom L, Wall S, et al. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality. J Med Screen 1996;3:129-32.
-
(1996)
J Med Screen
, vol.3
, pp. 129-132
-
-
Larsson, L.G.1
Nystrom, L.2
Wall, S.3
-
25
-
-
0242592073
-
Service screening with mammography of women aged 70-74 years in Sweden: Effects on breast cancer mortality
-
DOI 10.1016/S0361-090X(03)00131-4
-
Jonsson H, Tornberg S, Nystrom L, Lenner P. Service screening with mammography of women aged 70-74 years in Sweden. Effects on breast cancer mortality. Cancer Detect Prev 2003;27:360-9. (Pubitemid 37374932)
-
(2003)
Cancer Detection and Prevention
, vol.27
, Issue.5
, pp. 360-369
-
-
Jonsson, H.1
Tornberg, S.2
Nystrom, L.3
Lenner, P.4
-
26
-
-
62849118351
-
Trials of prostate-cancer screening are not worthwhile
-
Dubben HH. Trials of prostate-cancer screening are not worthwhile. Lancet Oncol 2009;10:294-8.
-
(2009)
Lancet Oncol
, vol.10
, pp. 294-298
-
-
Dubben, H.H.1
|